Document is current
Any future updates will be listed below
-
Authors
Wilk, Elizabeth J.
Howton, Timothy C.
Fisher, Jennifer L.
Oza, Vishal H.
Brownlee, Ryan T.
McPherson, Kasi C.
Cleary, Hannah L.
Yoder, Bradley K.
George, James F.
Mrug, Michal
Lasseigne, Brittany N. https://orcid.org/0000-0002-1642-8904
-
Funding
Funding for this research was provided by:
School of Medicine, University of Alabama at Birmingham (AMC21 Multi-PI 2021)
National Human Genome Research Institute (R00HG009678)
National Institute of Diabetes and Digestive and Kidney Diseases (NIH R25 DK 115353, NIH U54 DK126087)
Institutional Research and Academic Career Development Award (NIH K12 GM088010)
PKD Research Resource Consortium (U54DK126087, U54DK128128)
Office of Research and Development, Medical Research Service (1-I01-BX004232-01A2)
Detraz Endowed Research Fund in Polycystic Kidney Disease
Office of the Director (U54OD03016, R03OD030604)
- License Information
-
More Information
Article History
Received: 6 December 2022
Accepted: 10 May 2023
First Online: 22 May 2023
Declarations
:
: Not applicable.
: Not applicable.
: M. M. reports grants and consulting fees outside the submitted work from Otsuka Pharmaceuticals, Sanofi, Palladio Biosciences, Reata, Natera, Chinook Therapeutics, Goldilocks Therapeutics and Carraway Therapeutics.
